JCI vs KALA · P/E 44, rev $23.60B vs $54.3M cap
Johnson Controls International PLC (JCI) versus Kala Pharmaceuticals Inc (KALA) — a side-by-side from cached financials, not a winner call.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Kala Pharmaceuticals Inc (KALA) is a biotechnology company listed on NASDAQ.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Latest reported KALA revenue for 2025-12-31 was $0. Net income was -$27.0M. KALA currently screens at market cap $54.3M.
JCI currently screens at market cap $87.62B and trailing P/E 43.9. KALA currently screens at market cap $54.3M.
Not investment advice. Open the JCI and KALA stock pages for the full models.
Not investment advice.